PMID: 23104983

He L, Kota P, Aleksandrov AA, Cui L, Jensen T, Dokholyan NV, Riordan JR
Correctors of DeltaF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein.
FASEB J. 2013 Feb;27(2):536-45. doi: 10.1096/fj.12-216119. Epub 2012 Oct 26., [PubMed]
Sentences
No. Mutations Sentence Comment
11 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23104983:11:143
status: NEW
view ABCC7 p.Gly551Asp details
The effectiveness of this strategy is most convincingly demonstrated by the small-molecule VX-770 (Kalydeco) that overcomes the dysfunction of G551D CFTR present in a significant subset of patients and improves their epithelial salt and fluid homeostasis and lung function (5). Login to comment
13 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23104983:13:177
status: NEW
view ABCC7 p.Gly551Asp details
However, as yet, these so-called correctors have been much less effective in early clinical trials on patients with the èc;F508 mutation than VX-770 is on patients with the G551D mutation (5). Login to comment
43 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:43:83
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:43:385
status: NEW
view ABCC7 p.Ile539Thr details
Metabolic pulse chase BHK cells stably expressing èc;F508 CFTR with or without I539T were treated with VX-809 (3 òe;M; Vertex Pharmeceuti- cals, Cambridge, MA, USA) for 24 h at 27&#b0;C. Cells expressing wild-type (WT) CFTR were grown at 37&#b0;C. Long-term pulse-chase experiments were performed in the absence (WT CFTR) or the presence of VX-809 (èc;F508 and èc;F508/I539T CFTR) to follow the lifetime of mature CFTR (14). Login to comment
44 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:44:80
status: NEW
view ABCC7 p.Ile539Thr details
Briefly, BHK cells stably expressing WT CFTR, èc;F508 CFTR, and èc;F508/I539T CFTR were grown in 60-mm-diameter dishes and labeled for 8 h in 1.5 ml methionine-free medium supplemented with 10% normal growth medium, 10% FBS, and 66 òe;Ci/ml 35 S-methionine (Perkin-Elmer, Waltham, MA), at 27 or 37&#b0;C. Cells were then washed 2 times and chased at 37&#b0;C with growth medium supplemented with 10 mM unlabeled methionine. Login to comment
62 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:62:84
status: NEW
view ABCC7 p.Ile539Thr details
The transport capacity of the structural unit ᐹॹᐺ for èc;F508/I539T CFTR with unstable gating kinetics and variable conductive state at 35&#b0;C was estimated as total charge transported in 10 min (area under the trace), divided by the potential difference applied and normalized per second so as to be an exact analog of ॹPo used for the channels with stable and well-defined open state. Login to comment
77 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:77:79
status: NEW
view ABCC7 p.Ile539Thr details
Furthermore, even when the modestly effective second-site suppressor mutation, I539T (22, 23) also was present in VX-809-treated èc;F508-CFTR-ex- Figure 1. Login to comment
82 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:82:260
status: NEW
view ABCC7 p.Ile539Thr details
While these lifetimes as reflections of the stability of the protein in cells do not necessarily equate to the functional thermal stability of its ion channel activity, only very transient channel activity with low open probability was observed in èc;F508/I539T-CFTR-expressing cells treated with VX-809 (Fig. 2B). Login to comment
83 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:83:129
status: NEW
view ABCC7 p.Ile539Thr details
Thus, the shortened functional lifetime of the èc;F508-CFTR channel described previously (14, 25, 26) is not extended by the I539T substitution. Login to comment
84 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:84:24
status: NEW
view ABCC7 p.Ile539Thr details
We used the èc;F508/I539T- CFTR variant as it, in contrast to the èc;F508 CFTR (14), has reasonably stable functional activity at 25&#b0;C, although it inactivates at higher temperatures (24). Login to comment
85 ABCC7 p.Ser492Pro
X
ABCC7 p.Ser492Pro 23104983:85:146
status: NEW
view ABCC7 p.Ser492Pro details
Therefore, it serves as a basis for the comparison of the influence of the VX-809 compound with that of a known stabilizing second-site mutation, S492P (24). Login to comment
86 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:86:38
status: NEW
view ABCC7 p.Ile539Thr details
For VX-809 treatment, the èc;F508/I539T CFTR variant was continuously exposed to the compound during cell growth, membrane vesicle isolation, and channel assay. Login to comment
88 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:88:58
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ser492Pro
X
ABCC7 p.Ser492Pro 23104983:88:93
status: NEW
view ABCC7 p.Ser492Pro details
This behavior strongly contrasted that of the èc;F508/I539T variant with the stabilizing S492P mutation added, where transport capacity increased, and full conductance state persisted up to 35&#b0;C (compare tracings in Fig. 2Biii, iv). Login to comment
92 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:92:230
status: NEW
view ABCC7 p.Ile539Thr details
We employed this assay to compare the folded state of èc;F508 CFTR that had matured under the influence of the strongly NBD1-stabilizing 4PT modification (prolines introduced at 4 mobile sites: S422, S434, S492, and A534 plus I539T); or exposure of cells to VX-809 at 27&#b0;C. Login to comment
96 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:96:64
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:96:314
status: NEW
view ABCC7 p.Ile539Thr details
A) BHK cells stably expressing èc;F508 CFTR with or without I539T were treated with VX-809 (3 òe;M) for 24 h at 27&#b0;C. Cells expressing WT CFTR were grown at 37&#b0;C. Long-term pulse-chase experiments were performed in the absence of VX-809 (WT CFTR) or presence of VX-809 (èc;F508 and èc;F508/I539T CFTR) to follow the lifetime of CFTR, as described in Materials and Methods. Login to comment
98 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:98:44
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:98:150
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:98:252
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ser492Pro
X
ABCC7 p.Ser492Pro 23104983:98:156
status: NEW
view ABCC7 p.Ser492Pro details
B) Single-channel recordings of èc;F508/I539T CFTR (èc;F/T) rescued by 3 òe;M VX-809 at 35&#b0;C (i) and 25&#b0;C (ii) and of èc;F508/I539T/S492P CFTR (èc;F/PT) as an example of an already known (24) alternative type of èc;F508/I539T, thermally stabilized by proline substitutions at 35&#b0;C (iii) and 25&#b0;C (iv). Login to comment
99 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:99:154
status: NEW
view ABCC7 p.Ile539Thr details
Six independent experiments of 38 min total time were used to estimate transport capacity ᐹॹᐺ afd; 1.46 afe; 0.28 for èc;F508/I539T at 25&#b0;C; data are shown as means afe; se. Login to comment
100 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:100:136
status: NEW
view ABCC7 p.Ile539Thr details
Five independent experiments of 34 min total time were used to estimate ᐹॹᐺ afd; 0.35 afe; 0.14 for èc;F508/I539T at 35&#b0;C. Login to comment
101 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:101:258
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ser492Pro
X
ABCC7 p.Ser492Pro 23104983:101:264
status: NEW
view ABCC7 p.Ser492Pro details
Two sets of 4 independent experiments of 35 and 38 min total time were used to estimate transport capacity ᐹॹᐺ afd; 0.85 afe; 0.26 at 25&#b0;C (iii) and ᐹॹᐺ afd; 3.14 afe; 0.32 at 35&#b0;C (iv) for èc;F508/I539T/S492P CFTR. Login to comment
122 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:122:30
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ala534Pro
X
ABCC7 p.Ala534Pro 23104983:122:24
status: NEW
view ABCC7 p.Ala534Pro details
ABCC7 p.Ser434Pro
X
ABCC7 p.Ser434Pro 23104983:122:11
status: NEW
view ABCC7 p.Ser434Pro details
ABCC7 p.Ser422Pro
X
ABCC7 p.Ser422Pro 23104983:122:5
status: NEW
view ABCC7 p.Ser422Pro details
ABCC7 p.Ser492Pro
X
ABCC7 p.Ser492Pro 23104983:122:17
status: NEW
view ABCC7 p.Ser492Pro details
4PT, S422P/S434P/S492P/ A534P/I539T. Login to comment
126 ABCC7 p.Val510Cys
X
ABCC7 p.Val510Cys 23104983:126:120
status: NEW
view ABCC7 p.Val510Cys details
ABCC7 p.Gly1069Cys
X
ABCC7 p.Gly1069Cys 23104983:126:126
status: NEW
view ABCC7 p.Gly1069Cys details
ABCC7 p.Gln1280Cys
X
ABCC7 p.Gln1280Cys 23104983:126:110
status: NEW
view ABCC7 p.Gln1280Cys details
HEK293 cells were transiently transfected with Cys-less CFTR or Cys-less èc;F508 CFTR with Cys pairs 276C/Q1280C or V510C/G1069C, introduced at NBD2/CL2 and NBD1/CL4 interfaces, respectively (13). Login to comment
134 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:134:87
status: NEW
view ABCC7 p.Ile539Thr details
VX-809 treatment of the combined NBD1 signature suppressor mutations together with the I539T substitution (èc;F/4S) caused substantial further enhancement of maturation at both temperatures. Login to comment
135 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:135:246
status: NEW
view ABCC7 p.Ile539Thr details
With the strongly stabilizing regulatory insertion deletion (èc;RI), the compound caused large increments that were of equivalent magnitude at both temperatures, and a similar effect was observed with the proline insertions in the context of I539T variant (4PT). Login to comment
138 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:138:4
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:138:207
status: NEW
view ABCC7 p.Val510Asp details
The R1070W substitution in CL4 may do so by contributing to interactions among a cluster of aromatic residues at the interface that is weakened by the absence of F508 from the NBD1 surface (11), whereas the V510D mutation was proposed to provide a salt bridge with R1070 (31). Login to comment
139 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:139:153
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:139:4
status: NEW
view ABCC7 p.Val510Asp details
The V510D mutant on the NBD1 side of the interface is very sensitive to further enhancement of maturation by the compound, whereas that on the CL4 side (R1070W) responds only rather weakly (Fig. 5B). Login to comment
140 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:140:177
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:140:46
status: NEW
view ABCC7 p.Val510Asp details
This difference may reflect the fact that the V510D substitution stabilizes isolated NBD1 (32) in the absence of the rest of CFTR, as well as influencing the interface, whereas R1070W has only the latter effect. Login to comment
141 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:141:69
status: NEW
view ABCC7 p.Arg1070Trp details
One might speculate that the less substantial influence of VX-809 on R1070W/èc;F508 CFTR could possibly reflect similar effects of either the tryptophan residue or the aromatic small molecule to partially fill the void left by the absence of the F508 residue. Login to comment
142 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:142:99
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:142:89
status: NEW
view ABCC7 p.Val510Asp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:142:142
status: NEW
view ABCC7 p.Val510Asp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:142:186
status: NEW
view ABCC7 p.Val510Asp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:142:246
status: NEW
view ABCC7 p.Val510Asp details
Interestingly, as has already been observed by others (9), the influence of the combined V510D and R1070W substitutions is similar to that of V510D alone, which would not be expected if V510D were forming a salt bridge with R1070 but might be if V510D acted primarily to stabilize the NBD1 domain, as has been observed (32). Login to comment
148 ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:148:52
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Ile539Thr
X
ABCC7 p.Ile539Thr 23104983:148:158
status: NEW
view ABCC7 p.Ile539Thr details
ABCC7 p.Gly550Glu
X
ABCC7 p.Gly550Glu 23104983:148:58
status: NEW
view ABCC7 p.Gly550Glu details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 23104983:148:64
status: NEW
view ABCC7 p.Arg553Met details
ABCC7 p.Arg555Lys
X
ABCC7 p.Arg555Lys 23104983:148:70
status: NEW
view ABCC7 p.Arg555Lys details
ABCC7 p.Ala534Pro
X
ABCC7 p.Ala534Pro 23104983:148:152
status: NEW
view ABCC7 p.Ala534Pro details
ABCC7 p.Ser434Pro
X
ABCC7 p.Ser434Pro 23104983:148:140
status: NEW
view ABCC7 p.Ser434Pro details
ABCC7 p.Ser422Pro
X
ABCC7 p.Ser422Pro 23104983:148:134
status: NEW
view ABCC7 p.Ser422Pro details
ABCC7 p.Ser492Pro
X
ABCC7 p.Ser492Pro 23104983:148:146
status: NEW
view ABCC7 p.Ser492Pro details
A) èc;F508 with NBD1-stabilizing mutations: 4S, I539T/G550E/R553M/R555K; èc;RI, deletion of amino acid residues 404-435; 4PT, S422P/S434P/S492P/A534P/I539T. Login to comment
149 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:149:53
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:149:67
status: NEW
view ABCC7 p.Val510Asp details
B) èc;F508 with NBD1/CL4 interface substitutions R1070W and/or V510D. Login to comment
157 ABCC7 p.Arg1070Trp
X
ABCC7 p.Arg1070Trp 23104983:157:247
status: NEW
view ABCC7 p.Arg1070Trp details
ABCC7 p.Val510Asp
X
ABCC7 p.Val510Asp 23104983:157:257
status: NEW
view ABCC7 p.Val510Asp details
Interestingly, the patterns of enhancement by the compounds were remarkably similar for each of the three classes of NBD1 stabilizing mutations (èc;F/èc;RI, èc;F4S, and èc;F/4PT) with or without one of the interface substitutions (R1070W or V510D). Login to comment
167 ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 23104983:167:88
status: NEW
view ABCC7 p.Arg560Thr details
The èc;I507 mutant that also causes severe disease (36) was among those, as was the R560T missense mutation, prominent in some ethnic populations (37). Login to comment
181 ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 23104983:181:173
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Arg258Gly
X
ABCC7 p.Arg258Gly 23104983:181:116
status: NEW
view ABCC7 p.Arg258Gly details
ABCC7 p.Ser945Leu
X
ABCC7 p.Ser945Leu 23104983:181:133
status: NEW
view ABCC7 p.Ser945Leu details
ABCC7 p.His139Arg
X
ABCC7 p.His139Arg 23104983:181:103
status: NEW
view ABCC7 p.His139Arg details
B, C) HEK293 cells were transiently transfected with CFTR with misprocessing mutations located in CL1 (H139R), CL2 (R258G), and CL3 (S945L) (B), or in NBD1 (èc;I507 and R560T; C). Login to comment
197 ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 23104983:197:68
status: NEW
view ABCC7 p.Arg560Thr details
Two other severe disease-causing mutations in NBD1 (èc;I507 and R560T) that also were not temperature sensitive were unresponsive to VX-809. Login to comment